Table 2 Recommended treatment targets
From: A systematic review of guidelines for managing rheumatoid arthritis
| Guideline | Treatment Target | Remission Definitions | Treat Moderate Disease | |||||
|---|---|---|---|---|---|---|---|---|
| Remission | LDA | Suppress Inflammation | ||||||
| 1. American [14] | Yes | Yes | – | SDAI | Boolean | Yes | ||
| 2. APLAR [15] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
| 3. Australian [16] | Yes | – | – | – | – | – | – | Yes |
| 4. Brazilian [17] | Yes | Yes | DAS28 | SDAI | CDAI | – | Yes | |
| 5. British Columbia [18] | – | – | Yes | – | – | – | – | – |
| 6. British Society For Rheumatology: Established [19] | Yes | – | Yes | – | – | – | – | – |
| 7. British Society For Rheumatology: Early [20] | – | – | – | – | – | – | – | – |
| 8. Canadian [21] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
| 9. EULAR [22] | Yes | Yes | – | SDAI | Boolean | – | – | Yesa |
| 10. French [23] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
| 11. German [24] | Yes | Yes | – | DAS28 | – | – | – | Yesa |
| 12. Hong Kong [25] | Yes | – | – | DAS28 | – | – | – | Yesa |
| 13. Indian [26] | Yes | – | – | – | – | – | – | Yes |
| 14. Latin American [27] | Yes | Yes | – | DAS28 | – | – | – | – |
| 15. Mexican [28] | Yes | Yes | – | DAS28 | – | – | – | Yes |
| 16. England [29] | Yes | Yes | – | DAS28 | – | – | – | – |
| 17. Scotland [30] | Yes | Yes | – | DAS28 | – | – | – | Yes |
| 18. South African [31] | Yes | Yes | – | SDAI | – | – | – | Yes |
| 19. Spanish [32] | Yes | Yes | – | DAS28 | CDAI | Boolean | – | Yesa |
| 20. Swedish [33] | Yes | Yes | – | DAS28 | SDAI | CDAI | – | Yes |
| 21. Treat to Target [34] | Yes | Yes | – | DAS28 | SDAI | CDAI | Boolean | Yes |
| 22. Turkish [35] | Yes | Yes | – | – | – | – | – | Yes |